Moreover, their mouse model showed that co-expression of Sf3b1-K700E with Atm deletion in B cells leads to the development of low-penetrance CLL, whereas either lesion alone does not [142]. Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.